Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
Molecular Cancer Therapeutics|October 22, 2017
Caveolae-Mediated Endocytosis as a Novel Mechanism of Resistance to Trastuzumab Emtansine (T-DM1)Matthew Sung, Xingzhi Tan, Bingwen Lu, et al.
The Journal of Biological Chemistry|March 6, 2002
ANGPTL3 stimulates endothelial cell adhesion and migration via integrin alpha vbeta 3 and induces blood vessel formation in vivoGieri Camenisch, Maria Teresa Pisabarro, Daniel Sherman, et al.
Mabs|January 13, 2010
Anti-leukemic activity of lintuzumab (SGN-33) in preclinical models of acute myeloid leukemiaMay Kung Sutherland, Changpu Yu, Timothy S Lewis, et al.
Cell|March 12, 2003
HIF-1alpha is essential for myeloid cell-mediated inflammationThorsten Cramer, Yuji Yamanishi, Björn E Clausen, et al.
Plos One|July 21, 2017
Detecting expression of 5T4 in CTCs and tumor samples from NSCLC patientsSteven R Pirie-Shepherd, Cory Painter, Pamela Whalen, et al.
Molecular Cancer Therapeutics|September 16, 2008
Engineered anti-CD70 antibody-drug conjugate with increased therapeutic indexCharlotte F McDonagh, Kristine M Kim, Eileen Turcott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 30, 2016
Liver Microvascular Injury and Thrombocytopenia of Antibody-Calicheamicin Conjugates in Cynomolgus Monkeys-Mechanism and MonitoringMagali Guffroy, Hadi Falahatpisheh, Kathleen Biddle, et al.
Molecular Cancer Therapeutics|August 30, 2008
Anti-CD30 diabody-drug conjugates with potent antitumor activityKristine M Kim, Charlotte F McDonagh, Lori Westendorf, et al.
The New England Journal of Medicine|March 14, 2008
VEGF inhibition and renal thrombotic microangiopathyVera Eremina, J Ashley Jefferson, Jolanta Kowalewska, et al.
Blood|January 17, 2009
Potent antitumor activity of the anti-CD19 auristatin antibody drug conjugate hBU12-vcMMAE against rituximab-sensitive and -resistant lymphomasHans-Peter Gerber, May Kung-Sutherland, Ivan Stone, et al.
Pageof 8